The closing price of Surgepays Inc (NASDAQ: SURG) was $7.18 for the day, down -5.53% from the previous closing price of $7.60. In other words, the price has decreased by -$0.42 from its previous closing price. On the day, 798129 shares were traded.
Ratios:
Our analysis of SURG’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.81. For the most recent quarter (mrq), Quick Ratio is recorded 1.57 and its Current Ratio is at 2.57. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 when Cox Kevin Brian bought 5,200 shares for $4.72 per share. The transaction valued at 24,544 led to the insider holds 4,507,894 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SURG now has a Market Capitalization of 128.91M and an Enterprise Value of 121.71M. As of this moment, Surgepays’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.08, and their Forward P/E ratio for the next fiscal year is 4.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.88 while its Price-to-Book (P/B) ratio in mrq is 4.35. Its current Enterprise Value per Revenue stands at 0.86 whereas that against EBITDA is 5.29.
Stock Price History:
Over the past 52 weeks, SURG has reached a high of $9.23, while it has fallen to a 52-week low of $3.88. The 50-Day Moving Average of the stock is 7.12, while the 200-Day Moving Average is calculated to be 6.01.
Shares Statistics:
SURG traded an average of 651.35K shares per day over the past three months and 903.46k shares per day over the past ten days. A total of 14.12M shares are outstanding, with a floating share count of 11.51M. Insiders hold about 33.66% of the company’s shares, while institutions hold 7.72% stake in the company. Shares short for SURG as of Feb 15, 2024 were 1.98M with a Short Ratio of 3.04, compared to 2.16M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.69% and a Short% of Float of 17.55%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of $0.41 for the current quarter, with a high estimate of $0.51 and a low estimate of $0.28, while EPS last year was $0.25. The consensus estimate for the next quarter is $0.45, with high estimates of $0.54 and low estimates of $0.36.
Analysts are recommending an EPS of between $1.71 and $1.46 for the fiscal current year, implying an average EPS of $1.6. EPS for the following year is $1.75, with 3 analysts recommending between $2.29 and $1.44.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 3 analysts. It ranges from a high estimate of $35M to a low estimate of $32.08M. As of the current estimate, Surgepays Inc’s year-ago sales were $36.23M, an estimated decrease of -7.50% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $34.91M, a decrease of -4.40% over than the figure of -$7.50% in the same quarter last year. There is a high estimate of $35M for the next quarter, whereas the lowest estimate is $34.82M.
A total of 3 analysts have provided revenue estimates for SURG’s current fiscal year. The highest revenue estimate was $140M, while the lowest revenue estimate was $136.91M, resulting in an average revenue estimate of $138.4M. In the same quarter a year ago, actual revenue was $121.54M, up 13.90% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $145.89M in the next fiscal year. The high estimate is $148M and the low estimate is $141.83M. The average revenue growth estimate for next year is up 5.40% from the average revenue estimate for this year.
